Biomarker evaluation to support clinical translation in schizophrenia

Project Image:
Title of the project:
Biomarker evaluation to support clinical translation in schizophrenia
Teasertext:
Psychosis represents a group of diseases signified by enormous heterogeneity.
Project name:
Biomarker evaluation to support clinical translation in schizophrenia
Summary:
Psychosis represents a group of diseases signified by enormous heterogeneity. As a consequence, diagnosis, prognosis, and treatment decision for individual patients are pretty challenging.
Start:
01.09.2021
End:
31.08.2024
Project leader:
Prof. Dr. Hansjürgen Volkmer
Project funding:
  • BMBF
Project management:
  • DLR
Funding reference number:
01EK2101A
Description:

Psychosis represents a group of diseases signified by enormous heterogeneity. As a consequence, diagnosis, prognosis, and treatment decision for individual patients are pretty challenging. Within the project, we shall optimize biomarker signatures of patients with high risk for schizophrenia and with defined psychotic disease. This will be achieved by integration of multimodal patient data and subsequent validation of biomarker signatures with the help of patient-derived neurons.